Volume 14, Issue 2 (8-2023)                   JAP 2023, 14(2): 87-97 | Back to browse issues page

Ethics code: IR.PNU.REC.1401.075

XML Persian Abstract Print

1- Assistant Professor, Department of Psychology, Payam Noor University, Iran , dr_aghili1398@yahoo.com
2- Master of Psychology, Payam Noor University, Golestan, Iran
3- Assistant Professor, Department of Psychology, Faculty of Humanities, Kausar University of Bojnord, Bojnord, Iran
Abstract:   (249 Views)
Background and purpose: MS is one of the most common chronic diseases of the central nervous system. This disease causes many mental disorders in patients. The purpose of this study was to investigate the effectiveness of acceptance and commitment therapy on life expectancy and pain perception in patients with MS in Mashhad. Materials and methods: This was a semi-experimental study with a pre-test, post-test and control group design. The statistical population included all patients with MS in Hazrat Qaim (AS) hospital in Mashhad in 2022, from among whom 30 people were selected by available sampling method and randomly placed in two experimental and control groups, 15 people in each group. became The experimental group received 8 60-minute sessions of acceptance and commitment therapy, and the control group was placed on the waiting list. The research tool was Miller's Life Expectancy Questionnaire and McGill's Pain Perception Questionnaire. Research data were analyzed by multivariate covariance analysis and using SPSS version 21 software. Findings: The findings showed that acceptance and commitment therapy is effective on life expectancy and pain perception in patients with MS in Mashhad (P<0.05). Conclusion: Treatment based on acceptance and commitment can be a suitable treatment for improving the psychological factors of life expectancy and pain perception of patients with MS.
Full-Text [PDF 360 kb]   (135 Downloads)    
Type of Study: Applicable | Subject: Chronic pain managment
Received: 2023.03.20 | Accepted: 2023.06.17 | Published: 2023.08.1

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.